Oral anticoagulation and risk of death:: a medical record linkage study

被引:163
作者
Odén, A
Fahlén, M
机构
[1] S-442 92 Romelanda
[2] Department of Medicine, Hospital of Kungälv
来源
BMJ-BRITISH MEDICAL JOURNAL | 2002年 / 325卷 / 7372期
关键词
D O I
10.1136/bmj.325.7372.1073
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To study how mortality varies with different degrees of anticoagulation reflected by the international normalised ratio (INR). Design Record linkage analysis with death hazard estimated as a continuous function of INR. Data sources 46 anticoagulation clinics in Sweden with computerised medical records. Subjects Records for 42 451 patients, 3533 deaths, and 1.25 million INR measurements. Main outcome measures Mortality from all causes and from intracranial haemorrhage. Results Mortality from all causes of death was strongly related to level of INR. Minimum risk of death was attained at 2.2 INR for all patients and 2.3 INR for patients with mechanical heart valve prostheses. A high INR was associated with an excess mortality: with an increase of I unit of INR above 2.5, the risks of death from cerebral bleeding (149 deaths) and from any cause were about doubled. Among patients with an INR of greater than or equal to3.0, 1069 deaths occurred within 7 weeks; if the risk coincided with that with an INR of 2.9, the expected number of deaths would have been 569. Thus at least 500 deaths were associated with a high INR value, but not necessarily caused by the treatment. Conclusions The excess mortality associated with high INR values supports the use of less intensive treatment and a small therapeutic window, with INR close to 2.2-2.3 irrespective of the indication for anticoagulant treatment. More preventive actions should be taken to avoid episodes of high INR.
引用
收藏
页码:1073 / 1075
页数:3
相关论文
共 21 条
[1]   AREVA: Multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves [J].
Acar, J ;
Iung, B ;
Boissel, JP ;
Samama, MM ;
Michel, PL ;
Teppe, JP ;
Pony, JC ;
LeBreton, H ;
Thomas, D ;
Isnard, R ;
deGevigney, G ;
Viguier, E ;
Sfihi, A ;
Hanania, G ;
Ghannem, M ;
Mirode, A ;
Nemoz, C ;
Bossard, N ;
Rolland, C ;
Lion, L ;
Marsault, C ;
Ferroir, JP ;
Conard, J ;
Laborde, JP ;
Logeais, Y ;
Delahaye, JP ;
Guerin, F ;
Lainee, R ;
Lesbre, JP .
CIRCULATION, 1996, 94 (09) :2107-2112
[2]  
ALTMAN R, 1991, J THORAC CARDIOV SUR, V101, P427
[3]  
Breslow NE, 1987, STAT METHODS CANC RE, VII
[4]   COMPLICATIONS AND FAILURE OF ANTICOAGULATION THERAPY IN THE TREATMENT OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH DISSEMINATED MALIGNANCY [J].
CHAN, A ;
WOODRUFF, RK .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1992, 22 (02) :119-122
[5]   WARFARIN-INDUCED NECROSIS OF THE SKIN [J].
DEFRANZO, AJ ;
MARASCO, P ;
ARGENTA, LC .
ANNALS OF PLASTIC SURGERY, 1995, 34 (02) :203-208
[6]   OPTIMAL INTENSITY AND MONITORING WARFARIN [J].
HIRSH, J .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (06) :B39-B42
[7]   Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation [J].
Hylck, EM ;
Chang, YC ;
Skates, SJ ;
Hughes, RA ;
Singer, DE .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (11) :1612-1617
[8]   High concentration of thrombomodulin in plasma is associated with hemorrhage - A prospective study in patients receiving long-term anticoagulant treatment [J].
Jansson, JH ;
Boman, K ;
Brannstrom, M ;
Nilsson, TK .
CIRCULATION, 1997, 96 (09) :2938-2943
[9]  
Jansson JH, 1996, EUR HEART J, V17, P1503
[10]   Aortic valve replacement with the St. Jude Medical prosthesis and fixed dose anticoagulation [J].
Katircioglu, SF ;
Yamak, B ;
Ulus, AT ;
Iscan, HZ ;
Mavitas, B ;
Tasdemir, O .
JOURNAL OF CARDIAC SURGERY, 1997, 12 (06) :363-370